Intranasal delivery is discussed frequently for nootropic-adjacent compounds, with absorption assumptions rarely sourced.
Where this comes from
Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence. Observed in public discussion. PEPTD summarises the recurring theme — it does not republish anyone's post, profile or identity.
Community experience is anecdotal and is not medical advice. PEPTD does not convert discussion into recommended doses or protocols. Published research and regulatory sources are shown separately from public discussion.
Oral bioavailability is a persistent debate, with strong claims made in both directions and limited linking to pharmacokinetic literature.
From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.
Topical absorption questions come up across skin and hair discussion, often alongside cosmetic marketing claims.
From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.
From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.
